Peer Review History
| Original SubmissionSeptember 14, 2020 |
|---|
|
PONE-D-20-28913 Diarrhea Treatment Centre (DTC) based diarrheal disease surveillance in settlements in the wake of the mass influx of Forcibly Displaced Myanmar National (FDMN) in Cox’s Bazar, Bangladesh, 2018. PLOS ONE Dear Dr. Faruque, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Feb 12 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Ivan D. Florez Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Please include additional information regarding the survey or questionnaire used in the study and ensure that you have provided sufficient details that others could replicate the analyses. For instance, if you developed a questionnaire as part of this study and it is not under a copyright more restrictive than CC-BY, please include a copy, in both the original language and English, as Supporting Information. 3. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. In your revised cover letter, please address the following prompts: a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. We will update your Data Availability statement on your behalf to reflect the information you provide. 4. PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager. Please see the following video for instructions on linking an ORCID iD to your Editorial Manager account: https://www.youtube.com/watch?v=_xcclfuvtxQ 5. We note that you have included the phrase “data not presented” in your manuscript. Unfortunately, this does not meet our data sharing requirements. PLOS does not permit references to inaccessible data. We require that authors provide all relevant data within the paper, Supporting Information files, or in an acceptable, public repository. Please add a citation to support this phrase or upload the data that corresponds with these findings to a stable repository (such as Figshare or Dryad) and provide and URLs, DOIs, or accession numbers that may be used to access these data. Or, if the data are not a core part of the research being presented in your study, we ask that you remove the phrase that refers to these data. Additional Editor Comments: Your manuscript has been reviewed by two experts in the field, and they have found some points that need to be addressed before this manuscript is considered for publication. Please go through the reviewers' comments and consider addressing these points, and prepare a revised version. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: No Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: No Reviewer #2: No ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Abstract: � Study objectives should be clearly mentioned. � Materials and methods section should be more informative. For instance, the section should include information on the study design, study population, sampling technique, study tool and data analysis plan. Introduction: � Background information is nicely organized � Justification should be stronger. � Study objective is not clear. It should be clearly mentioned. Materials and methods: � Study design should come first, before study site and so on. � Why Bangladesh nationals were included as the study population? Including Bangladesh nationals might dilute the study findings. � Line 140-150: Unnecessary information. � Sample size: o Why the prevalence of enteric pathogen (0.3) was used for estimating sample size? Is this the main outcome variable? � Data collection: o How was the quality of the collected data ensured? � Statistical Analysis: o Please clearly state what are the outcome and explanatory variables. o Only descriptive statistics seems unsatisfactory for publishing in a renowned journal. Some sorts of inferential statistics should be performed (linear/logistic regression etc.). � Ethical consideration: o Please mention whether informed written consent was obtained or not? o What about anonymity and confidentiality? Results: � In the method section, it is stated that the study performed only descriptive analysis, however, in the result section “P-value” has been reported. Please explain how was the “P-value” obtained. � Formatting of the Tables should be improved by following those in international journals. Discussion: Discussion section should be enriched by explaining the study findings using existing literature. For instance, authors stated “This may be due to the increased vulnerability of females to diarrheal illnesses because of their higher compromised immunity or excess exposure to contaminated water and food during household activities.” (Line 312-314). This explanation should be backed up by relevant reference. Please mention the major strengths of the study. Adding a “Conclusion” section would be beneficial. Reviewer #2: GENERAL COMMENTS General editing for grammar and flow of the content It is not clear who the refugees are, where they immigrated from? Check on style of in-text citation especially where more than one article is citted. The numbers are separated with [] instead of commas. INTRODUCTION Line 66 – what is FDMN, write in full the first time. This goes for any abbreviation in the text. Lines 91-94- the authors have listed examples of basic services that were not adequate. Can the authors give examples of amounts of these services that were available for refugees? How did they determine that these services were not adequate? Lines 100-103- what were some specific findings from these initial assessments conducted by icddr,b, and UNICEF at the two mentioned sub-districts of Cox Bazar? Line 110-113- can the authors clarify to the readers if these locations: Leda (operated round-the-clock), Shyamlapur (round-the-clock), Balukhali (served as out-patient), Ukhiya (round-the-clock), and Teknaf (round-the-clock) in Cox’s Bazar district were camps where the were displaced populations were resettled or they were names of clinics? MATERIALS AND METHODS: STUDY POPULATIONS - were the settlements for displaced populations separate from where local populations were living or these two populations were integrated? What were the study objectives and hypothesis? DATA COLLECTION- were theses face to face interviews or they were a mixture of interviews and record reviews? For example how was the nutritional data collected? Please clarify how the different types of data was collected. RESULTS Generally, the authors have presented results on various variables by comparing the situations of displaced populations with local populations at the two study locations. However, what is not clear is how much of the basic services e.g. water, sanitation, food, health services were available to the two populations respectively. What types of food were available and how much? Were there feeding centers for the malnourished children? How much water on average was available per person per day? How were these services operated in the settlements? What were the shortfalls? Were the sphere standards met? When the authors assert that certain services were not adequate, what do they mean? The context of response by the government and relief agencies to the displaced and local populations need to be described more clearly. This will help with interpreting the findings and putting them within the context. Also the authors need to suggest some practical concrete recommendations. This can only be possible if they explain the current response situation and provision of services. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
|
| Revision 1 |
|
PONE-D-20-28913R1 Diarrhea Treatment Centre (DTC) based diarrheal disease surveillance in settlements in the wake of the mass influx of Forcibly Displaced Myanmar National (FDMN) in Cox’s Bazar, Bangladesh, 2018. PLOS ONE Dear Dr. Faruque, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. The manuscript represents original research, that is novel and does not appear to have been published elsewhere. The article is presented in an intelligible fashion and is written well. However, as described in the review below the outline of the research, description of the methods, statistics and analyses performed do not meet current standards for publication at this time. Please submit your revised manuscript by May 31 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Mark Simonds Riddle Academic Editor PLOS ONE [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: No ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: No ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: No ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Reviewer’s Comment: Article number: PONE-D-20-28913-R1 Title of the Article: Diarrhea Treatment Centre (DTC) based diarrheal disease surveillance in settlements in the wake of the mass influx of Forcibly Displaced Myanmar National (FDMN) in Cox’s Bazar, Bangladesh, 2018. Overall: The manuscript reported some important and interesting findings and used data from a satisfactorily designed study. However, the way the manuscript was written mostly seems with a report and not a journal article. A journal article usually identifies 2-4 specific research questions and keep focus to answer those questions throughout the document. In case of the current manuscript, that consistency and coherence is not properly maintained and the study objective is too broad. I would, therefore, suggest the authors to kindly identify 1-2 important research questions (e.g., nutritional status of women and children and their associated factors, WASH practice and its associated factors etc.) and keep focus on those aspects in the revised manuscript. Abstract: In the abstract, it is mentioned that “In total 1792 hospitalized individuals were considered as study participants”, however, in the main manuscript, sample size was estimated as 1050 (L 174). Kindly explain the discrepancy. Study objective: A journal article usually identifies 2-3 specific study objectives and keep focus to those throughout the manuscript. In case of the current manuscript, the study objective is too broad (to report the characteristics of the hospitalized patients in the newly deployed DTCs, focusing additionally on water and sanitation practices of the families, infant and young child feeding practices, nutritional status of the under-five children and women of childbearing age, and the associated common bacterial enteric pathogens and rotavirus). Moreover, consistency and coherence among study objective, method (specially outcome explanatory variables) and result is not properly maintained. I would, therefore, suggest the authors to kindly identify important key topics (e.g., nutritional status of women and children and their associated factors, WASH practice and its associated factors etc.) and keep focus on those aspects in the revised manuscript. Materials and methods Sample size: Authors considered the females aged 15 years and above hospitalized with acute watery diarrhea as the main outcome variable for sample size calculation (L 170-171), however, in the Statistical Analysis section (L 2014), they stated “Study population (displaced and host population) was our outcome variable”. Please explain this discrepancy. Statistical Analysis L 204-210: Authors stated “Study population (displaced and host population) was our outcome variable of interest. Explanatory variables included in the analysis were; demographic characteristics: age and sex; clinical features: duration of diarrhea, stool character, dehydration status, and ORS use; nutritional status: type of child nutrition, severe malnutrition of children, breastfeeding status of children 0-23 months old, and nutritional status of women 15-49 years; environmental factors: water source, and type of toilet use pattern; and associated common enteric pathogens: Vibrio cholerae O1, Shigella, Salmonella, and rotavirus”. This means in this study, the displaced and host population (outcome variable) was explained by (or depends on) age, sex, nutritional status, water source etc., which is logically not possible. Most importantly, the outcome variable should be any characteristic of study population and study population itself cannot be an outcome variable. Authors are kindly requested to clearly think about the outcome variable and explanatory variables and then perform analysis accordingly. L 220: Authors stated that "All explanatory variables were analyzed initially in a univariate model, and the attributes that were observed to be significantly associated (p-value <0.05) with the outcome variable (study population) were considered to be included in the multivariable logistic regression model". Why did the authors perform univariate analysis for explanatory variables but not for outcome variable given that for further analysis, univariate analysis of outcome variable is also important? L 230: Authors mentioned “A Goodness of fit test was run to test whether the model fitted well or not”. Which Goodness of fit test was used? L 233: The statement “p-value<0.05 was considered as the level of significance” is not correct. Level of significance (expressed as alpha or α) is the probability of rejecting the null hypothesis when it is true, whereas, p-value is the probability that an observed difference could have occurred just by random chance. P-value and α are inter-related, however, a p-value cannot be considered as the level of significance. Results L 316: The finding presented in the Table 3 indicates Nutritional status of children is the outcome variable and its distribution is shown across the type of population (all, displaced and host), which does not match with the outcome variable stated in the statistical analysis section (L 204). Please clearly identify the outcome variable of this paper. L 356: The sub-heading “Factors associated with hospitalization of the displaced population in DTCs” suggests that authors intended to identify which factors affected hospitalization of the displaced population, however, Table 6 indicates that they tried to compare WASH indicators (and NOT factors of hospitalization) between displaced and host population. On the other hand, the description under the sub-heading (e.g., hospitalized FDMN were significantly less likely to pass watery stool etc.) implies that the authors intended to identify difference in WASH indicators (such as watery vs. bloody diarrhoea) among hospitalized FDMN. Authors are kindly requested to thoroughly revise Table 6 and related description in the text to ensure alignment. Also, for multivariate regression tables, please report categories of covariates including reference category (e.g., variable: gender; category: male vs female, reference category: male). Please follow other articles published in Plos One for table formatting. Best wishes. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
Diarrhea Treatment Centre (DTC) based diarrheal disease surveillance in settlements in the wake of the mass influx of Forcibly Displaced Myanmar National (FDMN) in Cox’s Bazar, Bangladesh, 2018. PONE-D-20-28913R2 Dear Dr. Faruque, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Mark Simonds Riddle Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-20-28913R2 Diarrhea Treatment Centre (DTC) based diarrheal disease surveillance in settlements in the wake of the mass influx of Forcibly Displaced Myanmar National (FDMN) in Cox’s Bazar, Bangladesh, 2018. Dear Dr. Faruque: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Mark Simonds Riddle Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .